[HTML][HTML] EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood

M Weller, M van den Bent, M Preusser… - Nature reviews Clinical …, 2021 - nature.com
In response to major changes in diagnostic algorithms and the publication of mature results
from various large clinical trials, the European Association of Neuro-Oncology (EANO) …

Primary brain tumours in adults

MJ van den Bent, M Geurts, PJ French, M Smits… - The Lancet, 2023 - thelancet.com
The most frequent adult-type primary CNS tumours are diffuse gliomas, but a large variety of
rarer CNS tumour types exists. The classification of these tumours is increasingly based on …

Vorasidenib in IDH1-or IDH2-mutant low-grade glioma

IK Mellinghoff, MJ Van Den Bent… - … England Journal of …, 2023 - Mass Medical Soc
Background Isocitrate dehydrogenase (IDH)–mutant grade 2 gliomas are malignant brain
tumors that cause considerable disability and premature death. Vorasidenib, an oral brain …

Ultra-fast deep-learned CNS tumour classification during surgery

C Vermeulen, M Pagès-Gallego, L Kester… - Nature, 2023 - nature.com
Central nervous system tumours represent one of the most lethal cancer types, particularly
among children. Primary treatment includes neurosurgical resection of the tumour, in which …

Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised …

MJ van den Bent, CMS Tesileanu, W Wick… - The Lancet …, 2021 - thelancet.com
Background The CATNON trial investigated the addition of concurrent, adjuvant, and both
current and adjuvant temozolomide to radiotherapy in adults with newly diagnosed 1p/19q …

Clinical practice guidelines for the management of adult diffuse gliomas

T Jiang, DH Nam, Z Ram, W Poon, J Wang… - Cancer letters, 2021 - Elsevier
To follow the revision of the fourth edition of WHO classification and the recent progress on
the management of diffuse gliomas, the joint guideline committee of Chinese Glioma …

Predicting cancer outcomes from histology and genomics using convolutional networks

P Mobadersany, S Yousefi, M Amgad… - Proceedings of the …, 2018 - National Acad Sciences
Cancer histology reflects underlying molecular processes and disease progression and
contains rich phenotypic information that is predictive of patient outcomes. In this study, we …

[HTML][HTML] Evidence-based recommendations on categories for extent of resection in diffuse glioma

P Karschnia, MA Vogelbaum, M van den Bent… - European Journal of …, 2021 - Elsevier
Surgical resection represents the standard of care in diffuse glioma, and more extensive
tumour resection appears to be associated with favourable outcome. Up to now, terminology …

Isocitrate dehydrogenase (IDH) mutant gliomas: a Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions

JJ Miller, LN Gonzalez Castro, S McBrayer… - Neuro …, 2023 - academic.oup.com
Isocitrate dehydrogenase (IDH) mutant gliomas are the most common adult, malignant
primary brain tumors diagnosed in patients younger than 50, constituting an important cause …

Interactive effects of molecular, therapeutic, and patient factors on outcome of diffuse low-grade glioma

SL Hervey-Jumper, Y Zhang, JJ Phillips… - Journal of Clinical …, 2023 - ascopubs.org
PURPOSE In patients with diffuse low-grade glioma (LGG), the extent of surgical tumor
resection (EOR) has a controversial role, in part because a randomized clinical trial with …